Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-017770

Chief Financial Officer sold 1,461 shares at $16.74 ($24,457)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Koppikar Utpal Chief Financial Officer 2021-03-02 Sale −1,461 $16.74 $24,457 174,343 D
Open-market sales · 1,461 sh · avg $16.74 · $24,457
Loading xslF345X03/doc4.xml…